Funder
Deutsche Forschungsgemeinschaft
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Carrato, A. et al. A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs. J. Gastrointest. Cancer 46, 201–11 (2015).
2. Kamisawa, T., Wood, L. D., Itoi, T. & Takaori, K. Pancreatic cancer. Lancet 1–13 (2016).
3. Hidalgo, M. et al. Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology 15, 8–18 (2015).
4. Lovecek, M. et al. Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study. Biomed. Pap. 160, 280–286 (2016).
5. Conroy, T. et al. Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas. | 2018 ASCO Annual Meeting Abstracts. In ASCO Annual Meeting abstr LBA4001 (J Clin Oncol 36, 2018, 2018).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献